Digital Accessibility Statement

Laboratoire Aguettant is committed to making its websites, intranet, extranet, software packages and mobile applications accessible, in accordance with Article 47 of Law No. 2005-102 of 11 February 2005.

To this end, Laboratoire Aguettant is implementing the following strategy and actions:

This accessibility statement applies to the website: https://aguettant-corporate.com/fr/ 

Compliance status

The website https://aguettant-corporate.com/fr is partially compliant with the General Reference Framework for Accessibility Improvement (RGAA), version 4.1.2, due to the non-compliance items listed below.

Test results

The compliance audit carried out by the Novius agency shows that 64.40% of the RGAA version 4.1.2 criteria are met.

In detail:

  • Number of compliant criteria: 47
  • Number of non-compliant criteria: 26
  • Number of non-applicable criteria: 33

Our accessibility team is actively working to correct the criteria that remain non-compliant.

Inaccessible content

Non-compliance items

The content listed below is not accessible. Here is the list of non-compliant criteria:

1. Images

  • Criterion 1.2: Is each decorative image correctly ignored by assistive technologies?

→ Major

  • Criterion 1.3: For each image conveying information and having a text alternative, is this alternative relevant (except in special cases)?

→ Major

3. Colours

  • Criterion 3.1: On each web page, information must not be conveyed by colour alone. Is this rule respected?

→ Major

  • Criterion 3.2: On each web page, is the contrast between the text colour and its background colour sufficiently high (except in special cases)?

→ Major

4. Multimedia

  • Criterion 4.1: Does each pre-recorded time-based medium have, where necessary, a text transcript or audio description (except in special cases)?

→ Major

6. Links

  • Criterion 6.1: Is each link explicit (except in special cases)?

→ Major

  • Criterion 6.2: On each web page, does each link have a label?

→ Blocking

7. Scripts

  • Criterion 7.1: Is each script, where necessary, compatible with assistive technologies?

→ Major

  • Criterion 7.3: Is each script operable by keyboard and by any pointing device (except in special cases)?

→ Blocking

8. Mandatory elements

  • Criterion 8.6: For each web page that has a page title, is this title relevant?

→ Major

  • Criterion 8.7: On each web page, is each change of language indicated in the source code (except in special cases)?

→ Major

  • Criterion 8.9: On each web page, tags must not be used for presentation purposes only. Is this rule respected?

→ Minor

9. Structuring of information

  • Criterion 9.3: On each web page, is each list correctly structured?

→ Major

  • Criterion 9.4: On each web page, is each quotation correctly indicated?

→ Minor

10. Presentation of information

  • Criterion 10.6: On each web page, is each link whose nature is not obvious visible in relation to the surrounding text?

→ Blocking

  • Criterion 10.7: On each web page, for each element that receives focus, is the focus indicator visible?

→ Major

  • Criterion 10.11: For each web page, can the content be presented without loss of information or functionality, and without requiring either vertical scrolling for a window with a height of 256 px, or horizontal scrolling for a window with a width of 320 px (except in special cases)?

→ Blocking

11. Forms

  • Criterion 11.1: Does each form field have a label?

→ Blocking

  • Criterion 11.2: Is each label associated with a form field relevant (except in special cases)?

→ Major

  • Criterion 11.5: In each form, are fields of the same nature grouped together where necessary?

→ Major

  • Criterion 11.9: In each form, is the label of each button relevant (except in special cases)?

→ Major

  • Criterion 11.10: In each form, is input control used appropriately (except in special cases)?

→ Major

  • Criterion 11.11: In each form, is the input control accompanied, where necessary, by suggestions to help correct input errors?

→ Major

  • Criterion 11.13: Can the purpose of an input field be inferred to facilitate auto-filling of fields with user data?

→ Major

12. Navigation

  • Criterion 12.9: On each web page, navigation must not contain a keyboard trap. Is this rule respected?

→ Blocking

  • Criterion 12.11: On each web page, where necessary, can additional content appearing on hover, on focus, or on activation of an interface component be reached by keyboard?

→ Major

13. Consultation

  • Criterion 13.3: On each web page, does each downloadable office document have, where necessary, an accessible version (except in special cases)?

→ Major

Preparation of this accessibility statement

This statement was prepared on 01 April 2026.

Technologies used to build the website

  • HTML 5
  • CSS
  • JavaScript

Test environment

Content rendering checks were carried out using the combination provided in the RGAA reference base, with the following versions:

  • Google Chrome, Firefox + NVDA on Windows 11
  • Safari + VoiceOver on macOS 15

Tools used to assess accessibility

  • RGAA Assistant v4.1.2
  • WCAG Color Contrast Checker
  • HeadingsMap
  • Web Developer (code inspector)
  • ARC Toolkit
  • Wave (Web Accessibility Evaluation Tool)
  • PAC 2026 (PDF Accessibility Checker)
  • Accessibility Bookmarklets
  • Online tool app.asqatasun.org
  • Reference materials from the Temesis Auditor training course

Pages of the site covered by the compliance check

  1. Home page
    https://aguettant-corporate.com/fr/ 
  2. Contact
    https://aguettant-corporate.com/fr/contact/ 
  3. Legal notice
    https://aguettant-corporate.com/fr/mentions-legales/ 
  4. Privacy policy

https://aguettant-corporate.com/fr/politique-de-confidentialite/

  1. News

https://aguettant-corporate.com/fr/actualites/

  1. Join us

https://aguettant-corporate.com/fr/recrutement-offres-emploi/

  1. Aguettant, pharmaceutical laboratory

https://aguettant-corporate.com/fr/aguettant-laboratoire-pharmaceutique/

  1. The story of a commitment

https://aguettant-corporate.com/fr/aguettant-laboratoire-pharmaceutique/histoire-d-un-engagement/

  1. Our industrial sites

https://aguettant-corporate.com/fr/notre-presence-dans-le-monde/nos-sites-industriels/

  1. Our commercial subsidiaries

https://aguettant-corporate.com/fr/notre-presence-dans-le-monde/nos-filiales-commerciales/

  1. Expert in injectable medicines for hospitals

https://aguettant-corporate.com/fr/expert-du-medicament-injectable-a-l-hopital/

  1. Innovation & prefilled syringes

https://aguettant-corporate.com/fr/innovation-seringues-preremplies/

  1. Aguettant Academy

https://aguettant-corporate.com/aguettant-academy/

Feedback and contact

If you are unable to access content or a service, you may contact the person responsible for https://aguettant-corporate.com/fr/  to be directed to an accessible alternative or to obtain the content in another format.

  • Send a message [URL of the online form or contact e-mail address];
  • Contact [Name of the entity responsible for the online service and contact details].

Means of appeal

If you notice an accessibility failure preventing you from accessing content or a feature of the site, and after reporting it to us you do not receive a satisfactory response, you are entitled to send your complaint or a request to the Défenseur des droits (the French Rights Defender).

Several options are available to you:

Défenseur des droits

Libre réponse 71120

75342 Paris CEDEX 07


10 June 2026
The Aguettant Group Announces the Appointment of Philippe de Pougnadoresse as Chief Executive Officer (CEO) and Chairman of the Executive Board
Read the letter
chevron-uparrow-right